Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot

The rising incidence and persistent dismal 5-year overall survival of pancreatic ductal adenocarcinoma (PDAC) highlight the need for new effective systemic therapies. Immunotherapy has shown significant benefits in solid organ tumors, but has thus far been disappointing in the treatment of PDAC. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullman, Nicholas A., Burchard, Paul R., Dunne, Richard F., Linehan, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
REVIEW ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390820/
https://www.ncbi.nlm.nih.gov/pubmed/35839445
http://dx.doi.org/10.1200/JCO.21.02616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390820/
https://www.ncbi.nlm.nih.gov/pubmed/35839445
http://dx.doi.org/10.1200/JCO.21.02616

Ejemplares similares